Answers are grounded in this paper and cite their sources.
This editorial emphasizes the need to address physician misconceptions that drive the inappropriate and increasing use of unfractionated heparin over guideline-recommended low molecular weight heparin for acute pulmonary embolism in the US.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Maughan et al. (2025) conducted an editorial in acute pulmonary embolism. Low molecular weight heparin (LMWH) vs. Unfractionated heparin (UFH) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: